Home » NicOx Gets EMEA Validation of Naproxcinod MAA Submission
NicOx Gets EMEA Validation of Naproxcinod MAA Submission
NicOx S.A. announced that the European Medicines Agency (EMEA) has validated
the Marketing Authorization Application (MAA) for naproxcinod, which was submitted through the centralized procedure in December 2009.
TradingMarkets
TradingMarkets
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May